Profile data is unavailable for this security.
About the company
Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. Ultimovacs’ technology is based on preclinical and clinical research on immunotherapies conducted at the Oslo University Hospital. Ultimovacs is advancing a broad clinical development program with clinical trials in Europe, Australia and the U.S. The Company's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being developed as a therapeutic cancer vaccine which may serve as a platform for use in combination with other immuno-oncology drugs which require an ongoing T cell response for their mode of action.
- Revenue in NOK (TTM)0.00
- Net income in NOK-177.88m
- Incorporated2011
- Employees25.00
- LocationUltimovacs ASAUllernchausseen 64OSLO 0379NorwayNOR
- Websitehttps://ultimovacs.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biovica International AB | 7.35m | -125.82m | 194.44m | 32.00 | -- | 2.16 | -- | 26.46 | -2.12 | -2.12 | 0.1218 | 1.15 | 0.048 | 0.2322 | 6.50 | 227,843.80 | -82.20 | -51.94 | -99.16 | -58.18 | 94.34 | 181.68 | -1,712.00 | -2,217.41 | 3.04 | -- | 0.0749 | -- | 115.49 | 19.39 | -12.97 | -- | -54.31 | -- |
Kancera AB | 0.00 | -60.83m | 201.79m | 5.00 | -- | 2.13 | -- | -- | -0.7267 | -0.7267 | 0.00 | 0.7749 | 0.00 | -- | -- | 0.00 | -52.92 | -54.82 | -65.84 | -66.21 | -- | 96.28 | -- | -7,249.06 | -- | -- | 0.00 | -- | -- | -- | -23.64 | -- | -- | -- |
SenzaGen AB | -100.80bn | -100.80bn | 212.63m | 32.00 | -- | 2.63 | -- | -- | -- | -- | -- | 2.71 | -- | -- | -- | -- | -- | -25.84 | -- | -29.85 | -- | 68.62 | -- | -132.29 | 1.24 | -- | 0.0368 | -- | 19.39 | 90.32 | 11.30 | -- | -21.10 | -- |
Exact Therapeutics AS | 0.00 | -48.33m | 214.94m | 8.00 | -- | 4.77 | -- | -- | -1.51 | -1.51 | 0.00 | 1.41 | 0.00 | -- | -- | -- | -67.21 | -40.21 | -86.14 | -45.67 | -- | -- | -- | -- | -- | -16,578.57 | 0.0258 | -- | -- | -- | -20.52 | -- | -- | -- |
Abliva AB | 138.09k | -98.38m | 221.70m | 6.00 | -- | 3.26 | -- | 1,605.47 | -0.0924 | -0.0924 | 0.0001 | 0.05 | 0.0013 | -- | 0.0045 | -- | -88.80 | -74.59 | -96.20 | -86.98 | -21,359.13 | -- | -71,240.15 | -65,958.89 | -- | -- | 0.00 | -- | 341.94 | 93.89 | -12.02 | -- | -19.74 | -- |
Acousort AB | 4.33m | -17.92m | 232.57m | -- | -- | 11.55 | -- | 53.73 | -1.25 | -1.25 | 0.3048 | 1.34 | 0.1595 | 4.59 | 4.21 | -- | -66.05 | -48.62 | -99.10 | -69.77 | -117.16 | -68.05 | -414.04 | -299.58 | 2.72 | -- | 0.00 | -- | 11.51 | 38.81 | -24.01 | -- | -- | -- |
Thor Medical ASA | 0.00 | -5.56m | 243.78m | 1.00 | -- | 0.8915 | -- | -- | -0.0318 | -0.152 | 0.00 | 1.16 | 0.00 | -- | -- | 0.00 | -2.52 | -79.17 | -2.84 | -113.94 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Intervacc AB | 9.00m | -103.58m | 250.39m | 15.00 | -- | 1.13 | -- | 27.83 | -1.40 | -1.40 | 0.1221 | 2.91 | 0.0365 | 3.25 | 1.55 | 595,066.70 | -41.96 | -17.62 | -45.32 | -18.77 | -589.11 | -243.59 | -1,151.30 | -626.90 | 4.33 | -- | 0.0006 | -- | -17.23 | -25.79 | -60.31 | -- | -38.72 | -- |
Ultimovacs ASA | 0.00 | -177.88m | 275.59m | 25.00 | -- | 1.06 | -- | -- | -5.17 | -5.17 | 0.00 | 7.53 | 0.00 | -- | -- | 0.00 | -44.31 | -28.80 | -50.09 | -31.12 | -- | -- | -- | -- | -- | -- | 0.0136 | -- | -- | -- | -12.78 | -- | -45.35 | -- |
Ascelia Pharma AB | 0.00 | -89.47m | 314.07m | 13.00 | -- | 5.12 | -- | -- | -2.63 | -2.63 | 0.00 | 1.80 | 0.00 | -- | -- | 0.00 | -65.17 | -- | -78.39 | -- | -- | -- | -- | -- | -- | -- | 0.2302 | -- | -- | -- | 16.72 | -- | -- | -- |
Lumito AB (publ) | 17.14k | -25.88m | 322.71m | 14.00 | -- | 2.95 | -- | 18,832.78 | -0.1244 | -0.1244 | 0.00008 | 0.4649 | 0.0001 | -- | 0.1491 | 1,133.33 | -21.11 | -20.77 | -23.47 | -22.38 | 70,276.65 | -- | -150,998.50 | -- | 0.928 | -167.26 | 0.0944 | -- | -- | -- | 4.56 | -- | -- | -- |
Annexin Pharmaceuticals AB (publ) | 0.00 | -46.78m | 323.41m | 4.00 | -- | 35.15 | -- | -- | -0.1765 | -0.1765 | 0.00 | 0.0171 | 0.00 | -- | -- | 0.00 | -256.08 | -125.42 | -351.79 | -151.33 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -8.17 | -- | -- | -- |
Medivir AB | 7.79m | -97.29m | 327.88m | 10.00 | -- | 1.54 | -- | 42.06 | -1.46 | -1.46 | 0.1028 | 1.89 | 0.032 | -- | 1.56 | 773,300.00 | -40.00 | -28.91 | -47.20 | -34.77 | -888.81 | -467.42 | -1,248.18 | -675.96 | -- | -- | 0.0482 | -- | 73.16 | -20.39 | -0.6275 | -- | -47.96 | -- |
Lifecare ASA | 13.09m | -35.26m | 337.39m | 32.00 | -- | 4.18 | -- | 25.78 | -0.2454 | -0.2454 | 0.092 | 0.4163 | 0.1621 | -- | 4.90 | 408,943.10 | -43.60 | -40.00 | -49.97 | -45.26 | -- | -- | -269.03 | -175.53 | -- | -- | 0.1812 | -- | -40.88 | 30.29 | -101.74 | -- | -- | -- |
Guard Therapeutics Intrntnl AB (publ) | 0.00 | -88.61m | 344.29m | 6.00 | -- | 5.58 | -- | -- | -8.74 | -8.74 | 0.00 | 5.27 | 0.00 | -- | -- | -- | -75.10 | -69.56 | -91.32 | -78.62 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -0.4289 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Nordea Investment Management AB (Norway)as of 30 Apr 2024 | 707.18k | 2.06% |
Handelsbanken Fonder ABas of 31 May 2024 | 436.38k | 1.27% |
KLP Kapitalforvaltning ASas of 31 Mar 2023 | 348.42k | 1.01% |
Folketrygdfondetas of 31 Dec 2023 | 343.47k | 1.00% |
Sissener ASas of 31 Dec 2023 | 300.00k | 0.87% |
Danske Invest Asset Management ASas of 30 Apr 2024 | 246.03k | 0.72% |
Equinor Asset Management ASAas of 31 Dec 2023 | 161.48k | 0.47% |
DNB Asset Management ASas of 30 Apr 2024 | 156.84k | 0.46% |
Storebrand Asset Management ASas of 31 Jan 2024 | 142.36k | 0.41% |
Alfred Berg Kapitalforvaltning ASas of 31 May 2024 | 56.09k | 0.16% |